VBI Vaccines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	12.6	23.69	62.63	121.69	93.83	44.21
Short-Term Investments	-	-	-	-	25.28	-
Cash & Short-Term Investments	12.6	23.69	62.63	121.69	119.1	44.21
Cash Growth	-68.82%	-62.18%	-48.54%	2.18%	169.38%	-25.40%
Accounts Receivable	0.23	-	0.09	0.01	0.08	0.2
Other Receivables	1.51	1.27	4.03	1.44	7.83	0.24
Receivables	1.74	1.27	4.13	1.45	7.91	0.44
Inventory	9.94	8.5	6.6	2.58	2.15	1.08
Prepaid Expenses	1.6	2.28	2.31	2.37	1.57	1.02
Other Current Assets	0.49	0.5	2.03	2.2	1.31	0.21
Total Current Assets	26.36	36.23	77.69	130.28	132.04	46.96
Property, Plant & Equipment	11.04	11.91	15.57	14.38	12.28	11.65
Goodwill	1.11	1.13	2.13	2.26	2.26	2.21
Other Intangible Assets	35.73	36.5	58.35	62.09	62.16	60.76
Other Long-Term Assets	1.21	1.18	1.36	1.26	0.64	0.62
Total Assets	75.44	86.95	155.09	210.28	209.37	122.2
Accounts Payable	8.87	6.43	12.97	4.28	3.73	1.13
Accrued Expenses	5.36	5.63	13.85	15.3	11.23	11.88
Current Portion of Long-Term Debt	48.75	50.77	-	-	-	14.85
Current Portion of Leases	0.83	0.98	0.97	0.84	0.94	0.64
Current Unearned Revenue	9.62	7.28	0.41	0.53	0.26	0.88
Other Current Liabilities	4.17	4.66	8.74	11.65	1.18	0.38
Total Current Liabilities	77.59	75.74	36.94	32.59	17.35	29.76
Long-Term Debt	-	-	48.89	28.44	16.33	-
Long-Term Leases	1.14	1.3	2.37	2.52	0.62	0.82
Long-Term Unearned Revenue	1.61	1.83	2.2	2.28	2.85	2.91
Other Long-Term Liabilities	0.57	0.56	0.52	0.57	0.52	0.46
Total Liabilities	80.91	79.42	90.92	66.39	37.67	33.95
Common Stock	455.06	454.21	442.31	442.24	403.53	284.97
Additional Paid-In Capital	108.01	107.43	90.02	81.58	75.53	66.43
Retained Earnings	-600.35	-582.45	-489.61	-378.37	-308.62	-262.39
Comprehensive Income & Other	31.81	28.33	21.44	-1.57	1.27	-0.75
Shareholders' Equity	-5.47	7.53	64.16	143.88	171.71	88.26
Total Liabilities & Equity	75.44	86.95	155.09	210.28	209.37	122.2
Total Debt	50.71	53.04	52.23	31.8	17.89	16.3
Net Cash (Debt)	-38.12	-29.36	10.4	89.9	101.21	27.91
Net Cash Growth	-	-	-88.43%	-11.18%	262.64%	-38.31%
Net Cash Per Share	-1.95	-1.89	1.21	10.58	13.91	7.01
Filing Date Shares Outstanding	28.68	28.43	8.61	8.61	8.47	5.94
Total Common Shares Outstanding	25.24	23.92	8.61	8.61	8.23	5.94
Working Capital	-51.23	-39.51	40.75	97.7	114.69	17.21
Book Value Per Share	-0.22	0.31	7.45	16.71	20.85	14.85
Tangible Book Value	-42.31	-30.1	3.69	79.53	107.29	25.29
Tangible Book Value Per Share	-1.68	-1.26	0.43	9.24	13.03	4.26
Machinery	-	9.13	9.51	7.09	6.16	5.27
Leasehold Improvements	-	10.92	10.73	8.91	8.17	7.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.